NeuBase Therapeutics, Inc. (NBSE) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NBSE Hot Sheet
Join SI Premium – FREE
NeuBase Therapeutics, Inc. (NASDAQ: NBSE) reported Q2 EPS of ($0.12), in-line with the analyst estimate of ($0.12).
For earnings history and earnings-related data on NeuBase Therapeutics, Inc. (NBSE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
- Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
